Pangaea Oncology, S.A. (BME:PANG)

Pangaea Oncology Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.98	3.34	1.38	7.1	2.02
Short-Term Investments	1.1	1.1	1.41	1.41	0.91
Cash & Short-Term Investments	3.07	4.43	2.79	8.51	2.93
Cash Growth	-30.66%	58.86%	-67.22%	190.44%	149.16%
Accounts Receivable	6.92	7.26	5.67	3.66	3.6
Other Receivables	0.63	0.72	0.63	0.73	0.49
Receivables	7.55	7.98	6.3	4.38	4.08
Inventory	0.72	0.7	0.54	0.41	0.51
Other Current Assets	1.54	-	-	-	-
Total Current Assets	12.87	13.12	9.63	13.31	7.52
Property, Plant & Equipment	1.22	0.9	0.55	0.35	0.43
Long-Term Investments	0.03	0.06	0	0.49	0.57
Goodwill	2.14	2.42	3.22	0.55	-10.59
Other Intangible Assets	1.64	2.5	3.51	1.39	3.72
Long-Term Deferred Tax Assets	2.97	2.89	2.69	3.98	4.01
Long-Term Deferred Charges	11.18	10.47	9.18	8.25	15.14
Other Long-Term Assets	0.05	0.05	0.05	0.05	0.04
Total Assets	32.11	32.41	28.83	28.38	20.85

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.65	2.23	2.33	0.86	0.74
Accrued Expenses	0.41	0.83	0.44	0.13	0.13
Short-Term Debt	0.04	0.03	0.09	-	-
Current Portion of Long-Term Debt	3.26	3.58	2.61	1.21	1.62
Current Portion of Leases	0.02	0.02	-	-	-
Current Income Taxes Payable	-	-	0.06	-	-
Other Current Liabilities	0.87	0.32	1.65	0.52	0.7
Total Current Liabilities	7.25	7.01	7.17	2.72	3.18
Long-Term Debt	1.4	0.78	0.68	1.23	1.93
Long-Term Leases	0.02	0.04	-	-	-
Long-Term Deferred Tax Liabilities	0.6	0.81	0.99	0.29	0.31
Other Long-Term Liabilities	0.77	0.93	1.18	1.06	1.34
Total Liabilities	10.05	9.57	10.03	5.3	6.76

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.72	0.69	0.61	0.61	0.45
Additional Paid-In Capital	37.69	34.79	28.51	28.51	16.31
Retained Earnings	-17.88	-13.32	-11.83	-7.85	-4.49
Treasury Stock	-0.48	-0.47	-0.45	-0.07	-0.09
Comprehensive Income & Other	1.25	0.42	0.99	1.7	1.91
Total Common Equity	21.3	22.1	17.82	22.89	14.09
Minority Interest	0.76	0.73	0.98	0.18	-
Shareholders' Equity	22.06	22.84	18.81	23.08	14.09
Total Liabilities & Equity	32.11	32.41	28.83	28.38	20.85

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.74	4.45	3.38	2.44	3.55
Net Cash (Debt)	-1.66	-0.02	-0.59	6.08	-0.62
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.05	-	-0.02	0.20	-0.03
Filing Date Shares Outstanding	35.91	-	30.14	30.44	22.53
Total Common Shares Outstanding	35.91	-	30.14	30.44	22.53
Working Capital	5.62	6.11	2.46	10.58	4.34
Book Value Per Share	0.59	-	0.59	0.75	0.63
Tangible Book Value	17.52	17.18	11.1	20.95	20.95
Tangible Book Value Per Share	0.49	-	0.37	0.69	0.93
Buildings	0.48	0.23	0.07	0.07	0.07
Machinery	0.63	0.6	0.6	0.6	0.59

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 24, 2026

Data Sources Report a data error